{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:38:50Z","timestamp":1791549530293,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101765","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T19:23:20Z","timestamp":1734031400000},"page":"101765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD \u2013 a prospective interventional study"],"prefix":"10.1016","volume":"30","author":[{"given":"Adam","family":"Va\u0161ura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ev\u017een","family":"Machytka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Mach\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubom\u00edr","family":"Pavliska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Berka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"\u0160vagera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Bu\u017ega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2024.101765_bib0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0002","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"Marchesini","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155217","article-title":"A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on","volume":"133","author":"Boutari","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2024.101765_bib0004","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence","author":"Younossi","year":"2015","journal-title":"Incidence, and Outcomes"},{"key":"10.1016\/j.aohep.2024.101765_bib0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0006","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101765_bib0007","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.jhep.2023.08.003","article-title":"Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD","volume":"80","author":"Zhao","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12123860","article-title":"Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review","volume":"12","author":"Parra-Vargas","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2024.101765_bib0009","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 Annual report of the european liver transplant registry (ELTR) \u201350-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.aohep.2024.101765_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/lt.25657","article-title":"Nonalcoholic steatohepatitis after liver transplantation","volume":"26","author":"Cotter","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.aohep.2024.101765_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5009\/gnl19069","article-title":"Extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"14","author":"Li","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.aohep.2024.101765_bib0012","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0013","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101765_bib0014","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2024.101765_bib0015","doi-asserted-by":"crossref","first-page":"E733","DOI":"10.1055\/a-1880-2388","article-title":"Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (nafld) issued by the german society of gastroenterology, digestive and metabolic diseases (dgvs) - april 2022 - awmf registration no: 021-025","volume":"60","author":"Tacke","year":"2022","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101765_bib0016","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.aohep.2024.101765_bib0017","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2024.101765_bib0018","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","article-title":"Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial","volume":"10","author":"Gastaldelli","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.aohep.2024.101765_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021703","article-title":"GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives","volume":"24","author":"Nevola","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2024.101765_bib0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.aohep.2024.101765_bib0021","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/dom.13584","article-title":"Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes","volume":"21","author":"Cusi","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.aohep.2024.101765_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/dc19-0641","article-title":"Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial","volume":"43","author":"Kahl","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2024.101765_bib0023","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00125-018-4675-2","article-title":"Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study","volume":"61","author":"Eriksson","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.aohep.2024.101765_bib0024","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/dc19-0641","article-title":"Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial","volume":"43","author":"Kahl","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2024.101765_bib0025","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/ajg.2017.170","article-title":"Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis","volume":"112","author":"Kamal","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101765_bib0026","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2024.101765_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo11020073","article-title":"Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled trials","volume":"11","author":"Mantovani","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.aohep.2024.101765_bib0028","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101765_bib0029","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, randomized, controlled trial of resmetirom in nash with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2024.101765_bib0030","article-title":"FDA approves first treatment for patients with liver scarring due to fatty liver disease","year":"2024","journal-title":"FDA"},{"key":"10.1016\/j.aohep.2024.101765_bib0031","article-title":"S3-Leitlinie: chirurgie der adipositas und metabolischer erkrankungen","author":"DDD-BDDDVV","year":"2018","journal-title":"Version"},{"key":"10.1016\/j.aohep.2024.101765_bib0032","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2018.10.017","article-title":"Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0033","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s11695-017-2925-x","article-title":"Significant liver-related morbidity after bariatric surgery and its reversal\u2014a case series","volume":"28","author":"Eilenberg","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.aohep.2024.101765_bib0034","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11695-017-3028-4","article-title":"Liver dysfunction with both roux-en-y and one-anastomosis gastric bypass is almost exclusively seen with longer than standard limb lengths","volume":"28","author":"Mahawar","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.aohep.2024.101765_bib0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.soard.2015.10.077","article-title":"Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials","volume":"12","author":"Moura","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.aohep.2024.101765_bib0036","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s11695-020-04558-5","article-title":"Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Kotinda","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.aohep.2024.101765_bib0037","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4254\/wjh.v13.i7.815","article-title":"Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"de Freitas J\u00fanior","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0038","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11695-020-05084-0","article-title":"Efficacy and safety of intragastric balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a comprehensive review and meta-analysis","volume":"31","author":"Chandan","year":"2021","journal-title":"Obes Surg"},{"key":"10.1016\/j.aohep.2024.101765_bib0039","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.gie.2009.06.036","article-title":"Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients","volume":"71","author":"Forlano","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.aohep.2024.101765_bib0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cgh.2020.04.068","article-title":"Intragastric balloon placement induces significant metabolic and histologic improvement in patients with nonalcoholic steatohepatitis","volume":"19","author":"Bazerbachi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0041","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/liv.14917","article-title":"Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis","volume":"41","author":"Salomone","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2024.101765_bib0042","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s11739-023-03417-2","article-title":"Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease","volume":"18","author":"van Dijk","year":"2023","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.aohep.2024.101765_bib0043","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.gie.2012.05.023","article-title":"Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study","volume":"76","author":"Lee","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.aohep.2024.101765_bib0044","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.gie.2020.08.023","article-title":"Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty","volume":"93","author":"Hajifathalian","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.aohep.2024.101765_bib0045","first-page":"116","article-title":"EndoBarrier gastrointestinal liner in type 2 diabetic patients improves liver fibrosis as assessed by liver elastography","volume":"125","author":"Gollisch","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.aohep.2024.101765_bib0046","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gutjnl-2019-318349","article-title":"Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study","volume":"69","author":"Van Baar","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2024.101765_bib0047","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2024.101765_bib0048","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101765_bib0049","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.25993","article-title":"Determination of reliability criteria for liver stiffness evaluation by transient elastography","volume":"57","author":"Boursier","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101765_bib0050","article-title":"Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery","volume":"10","author":"Giuffr\u00e8","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.aohep.2024.101765_bib0051","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.ultrasmedbio.2019.06.415","article-title":"Abdominal wall thickness affects liver stiffness measurements by 2-d shear wave elastography in patients with chronic liver disease","volume":"45","author":"Cho","year":"2019","journal-title":"Ultrasound Med Biol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:32:07Z","timestamp":1777782727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124005489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124005489"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101765","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD \u2013 a prospective interventional study","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101765"}}